Patent details

EN | LT

LT - 1,2-Disubstituted 4-benzylamino-pyrrolidine derivatives as CETP inhibitors useful for the treatment of diseases such as hyperlipidemia or arteriosclerosis

EN - 1,2-Disubstituted 4-benzylamino-pyrrolidine derivatives as CETP inhibitors useful for the treatment of diseases such as hyperlipidemia or arteriosclerosis

Legal status

Patent not validated

Bibliographic data

Indications of the International Patent Classification (IPC)
(51)	INT.CL.	C07D 207/14
		C07D 403/12
		C07D 403/14
		C07D 401/14
		C07D 405/14
		C07D 413/14
		A61K 31/40
		A61P 3/06

European patent
(11)	Number of the document	2404901
(13)	Kind of document	T
(96)	European patent application number	11184000.5
	Date of filing the European patent application	2008-12-01
(97)	Date of publication of the European application	2012-01-11
(45)	Date of publication and mention of the grant of the patent	2013-05-22
(46)	Date of publication of the claims translation

Priority applications
(30)	Number	Date	Country code
	991891 P	2007-12-03	US

Inventors
(72)	Mogi, Muneto, US Kawanami, Toshio, US Yamada, Ken, US Yasoshima, Kayo, US Imase, Hidetomo, US Miyake, Takahiro, JP Ohmori, Osamu, JP

Grantee
(73)	Novartis AG, Lichtstrasse 35, 4056 Basel, CH

Title
(54)	1,2-Disubstituted 4-benzylamino-pyrrolidine derivatives as CETP inhibitors useful for the treatment of diseases such as hyperlipidemia or arteriosclerosis
	1,2-Disubstituted 4-benzylamino-pyrrolidine derivatives as CETP inhibitors useful for the treatment of diseases such as hyperlipidemia or arteriosclerosis